Furthermore, we established therapeutic antibodies targeting PD‐1 and PD‐L1 and reported their therapeutic efficacy against bovine leukemia virus infection,17, 18, 19 Johne's disease,20 mycoplasmosis,21 and canine malignant melanoma.22, 23. The gene discussed is CD274; the disease is Mycoplasmoides infection.